GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (AQSE:HCM.GB) » Definitions » Price-to-Funds-From-Operations

HUTCHMED (China) (AQSE:HCM.GB) Price-to-Funds-From-Operations : (As of Dec. 15, 2024)


View and export this data going back to 2015. Start your Free Trial

What is HUTCHMED (China) Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


HUTCHMED (China) Business Description

Address
2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.